Institutional investors hold a majority ownership of CELG through the 82.47% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STANDARD LIFE INVESTMENTS LTD. Bought 95.7 Thousand shares of Celgene
CANDRIAM BELGIUM SA Bought 47.8 Thousand shares of Celgene
LYXOR INTERNATIONAL ASSET MANAGE... Bought 35.3 Thousand shares of Celgene